Inclusion Criteria:
  -  Aged between 12 and to 17 with a minimum body weight of 40 kg
  -  Diagnosis of atopic dermatitis (AD) for at least 1 year and current status of moderate to severe disease (>= the following scores: BSA 10%, IGA 3, EASI 16, Pruritus NRS severity 4)
Exclusion Criteria:
  -  Acute or chronic medical or laboratory abnormality that may increase the risk associated with study participation
  -  Unwilling to discontinue current AD medications prior to the study or require treatment with prohibited medications during the study
  -  Prior treatment with JAK inhibitors
  -  Other active non-AD inflammatory skin diseases or conditions affecting skin
  -  Medical history including thrombocytopenia, coagulopathy or platelet dysfunction, malignancies, current or history of certain infections, lymphoproliferative disorders and other medical conditions at the discretion of the investigator
  -  Pregnant or breastfeeding women, or women of childbearing potential who are unwilling to use contraception